Miao Han

Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non–Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel

Jing Zhao, Guoqiang Wang, Jun Zhao, 2019, JAMA oncology.

Comutations in DNA Damage Response Pathways Serve as Potential Biomarkers for Immune Checkpoint Blockade.

T. Mok, Zemin Zhang, Shuhang Wang, 2018, Cancer research.

Identification of predictors of drug sensitivity using patient-derived models of esophageal squamous cell carcinoma

A. Futreal, Fugen Li, Jianjun Zhang, 2019, Nature Communications.

Targeted deep sequencing contributes to guiding personalized targeted therapy for advanced biliary tract cancer patients with non-radical resection: A real-world study

Fugen Li, Dadong Zhang, Yong Yu, 2020, Oncology reports.